|
|
Volumn 13, Issue 7 Suppl 11, 2008, Pages 15-21
|
|
Treating depression with SNRIs: who will benefit most?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL;
CYCLOPROPANE DERIVATIVE;
CYTOCHROME P450 2D6;
MILNACIPRAN;
SEROTONIN UPTAKE INHIBITOR;
BLOOD;
DEPRESSION;
GENETIC POLYMORPHISM;
GENETICS;
HUMAN;
META ANALYSIS;
PHARMACOGENETICS;
REVIEW;
CYCLOPROPANES;
CYTOCHROME P-450 CYP2D6;
DEPRESSION;
HUMANS;
META-ANALYSIS AS TOPIC;
METHOXYHYDROXYPHENYLGLYCOL;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
SEROTONIN UPTAKE INHIBITORS;
MLCS;
MLOWN;
|
|
EID: 67649388554
PISSN: 10928529
EISSN: None
Source Type: Journal
DOI: 10.1017/s1092852900028273 Document Type: Review |
|
Times cited : (3)
|
|
References (32)
|
